DrNicole Wong Doo

MBBS (Hons), PhD, FRACP, FRCPA, GradCert(ClnTch)

Dr Nicole Wong Doo (MBBS (Hons), PhD, FRACP, FRCPA, GradCert[ClinTch]) is a clinical and laboratory haematologist at Concord Repatriation General Hospital, senior lecturer at Concord Clinical School and Honorary Research Associate at the Cancer Council Victoria. In 2023, she was appointed as NSW Councillor of the Haematology Society of Australia and New Zealand.

As the Director of the Haematology Clinical Research Unit at Concord Hospital, she leads a team of 20 in the delivery of clinical trials embedded within clinical practice and clinical-translational research. Since completing a PhD in lymphoma and myeloma epigenetics at the University of Melbourne, she has built a growing portfolio of clinical research, as the Australian principal investigator of the ALLG HD13 RADAR trial in hodgkin lymphoma supported by the MRFF. She has ongoing research interests in lymphoma and multiple myeloma clinical trials and supportive care, including being a member of the ALLG Multiple Myeloma, Lymphoma and Supportive Care Scientific Working Parties, member of the Australasian Lymphoma Alliance and on the Steering Committee of the Australasian Myeloma Research Consortium. With a growing profile in patient-reported outcomes (PRO) research, she leads a PRO study in Oral therapy for Blood Diseases and is PI of a digital research project called MyHodgkin MyHealth, a mobile App for patient-entered health outcomes in Hodgkin lymphoma.

Dr Wong Doo is dedicated to promoting excellence in Haematology in the Asia-Pacific region and works to deliver training and education as a member of the Royal College of Pathologists Australasia Pathology Education Outreach Committee (PEOC).